Skip to main content
Tech.euFundingExplorerBeta

Jeito Capital

Investor profile

Jeito Capital has backed 10 European tech companies across 12 funding rounds between 2020 and 2025, joining rounds totalling €912M. Most active in Healthtech. Data as of Nov 2026.

Deals
12
distinct rounds
Companies
10
backed
Active span
2020–2025
6 yrs
Total round €
€912M
sum of rounds joined

Deals by year

distinct rounds / year
Jeito Capital — deals by year — interactive chart.
Data table
Jeito Capital — deals by year
20201
20211
20225
20232
20241
20252

Top sectors

by deals
Jeito Capital — top sectors — interactive chart.
Data table
Jeito Capital — top sectors
Healthtech12

Stages

by deals
Jeito Capital — stages — interactive chart.
Data table
Jeito Capital — stages
Series B6
Series A3
Other2
Series C1

Countries

by deals
Jeito Capital — countries — interactive chart.
Data table
Jeito Capital — countries
Switzerland3
UK3
Netherlands2
Belgium1
Denmark1
France1
Germany1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Jeito Capital — 12 dealsJeito CapitalForbion — 5 shared deals · click to openForbionSV Health Investors — 3 shared deals · click to openSV Health InvestorsUPMC Enterprises — 3 shared deals · click to openUPMC EnterprisesGilde Healthcare — 2 shared deals · click to openGilde HealthcareINKEF Capital — 2 shared deals · click to openINKEF CapitalInvus — 2 shared deals · click to openInvusMRL Ventures Fund — 2 shared deals · click to openMRL Ventures FundNovo Holdings — 2 shared deals · click to openNovo HoldingsPolaris Partners — 2 shared deals · click to openPolaris PartnersSamsara Biocapital — 2 shared deals · click to openSamsara BiocapitalSofinnova Partners — 2 shared deals · click to openSofinnova PartnersSyncona Partners — 2 shared deals · click to openSyncona PartnersYsios Capital — 2 shared deals · click to openYsios Capital4BIO Capital — 1 shared deals · click to open4BIO CapitalALSA Ventures — 1 shared deals · click to openALSA VenturesAXA IM Alts — 1 shared deals · click to openAXA IM AltsBain Capital Life Sciences — 1 shared deals · click to openBain Capital Life SciencesBayern Kapital — 1 shared deals · click to openBayern Kapital

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Quell TherapeuticsUK1€138M
Noema PharmaSwitzerland2€134M
AzafarosNetherlands1€132M
EyeBiotechUK2€118M
Neogene TherapeuticsNetherlands1€93M
PrecirixBelgium1€80M
SparingvisionFrance1€75M
ReproNovoSwitzerland1€57M
CatalYmGermany1€50M
NMD PharmaDenmark1€35M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Quell TherapeuticsSeries B€138M2021-11
AzafarosSeries B€132M2025-05
Noema PharmaSeries B€105M2023-03
Neogene TherapeuticsOther€93M2020-09
PrecirixSeries B€80M2022-03
SparingvisionSeries B€75M2022-09
EyeBiotechSeries A€61M2023-11
EyeBiotechSeries A€57M2022-02
ReproNovoSeries A€57M2025-05
CatalYmSeries C€50M2022-11
← Back to investors